Trinity Biotech Plc Stock Filter Stocks by Fundamentals
| TRIB Stock | USD 0.72 0.01 1.37% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Trinity Biotech's long-term financial health and intrinsic value.
Trinity | Shares Owned by Insiders | Build AI portfolio with Trinity Stock |
Trinity Biotech Institutional Holders
Institutional Holdings refers to the ownership stake in Trinity Biotech that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Trinity Biotech's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Trinity Biotech's value.| Shares | Two Sigma Investments Llc | 2025-03-31 | 15.1 K | Integrys Wealth Advisors Llc | 2025-06-30 | 10 K | Advisor Group Holdings, Inc. | 2025-03-31 | 4.5 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 2.2 K | Rhumbline Advisers | 2025-03-31 | 1.3 K | Jones Financial Companies Lllp | 2025-03-31 | 468 | Atlantic Trust Group, Llc | 2025-03-31 | 222 | Simplex Trading, Llc | 2025-03-31 | 215 | Bank Of America Corp | 2025-03-31 | 40.0 | Hunter Associates Inc. | 2025-03-31 | 375.1 K | Whitefort Capital Management, Lp. | 2025-03-31 | 81.9 K |
Trinity Fundamentals
| Return On Equity | -19.13 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.52) % | ||||
| Operating Margin | (0.43) % | ||||
| Current Valuation | 109.21 M | ||||
| Shares Outstanding | 18.63 M | ||||
| Shares Owned By Insiders | 12.01 % | ||||
| Shares Owned By Institutions | 4.62 % | ||||
| Number Of Shares Shorted | 804.76 K | ||||
| Price To Earning | 31.00 X | ||||
| Price To Book | 5.11 X | ||||
| Price To Sales | 0.22 X | ||||
| Revenue | 61.55 M | ||||
| Gross Profit | 21.44 M | ||||
| EBITDA | (16.91 M) | ||||
| Net Income | (31.79 M) | ||||
| Cash And Equivalents | 10.01 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 100.76 M | ||||
| Current Ratio | 3.66 X | ||||
| Book Value Per Share | (1.96) X | ||||
| Cash Flow From Operations | (4.19 M) | ||||
| Short Ratio | 0.85 X | ||||
| Earnings Per Share | (1.80) X | ||||
| Price To Earnings To Growth | 1.30 X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 401 | ||||
| Beta | 0.81 | ||||
| Market Capitalization | 13.42 M | ||||
| Total Asset | 103.29 M | ||||
| Retained Earnings | (79.12 M) | ||||
| Working Capital | 9.03 M | ||||
| Current Asset | 151 M | ||||
| Current Liabilities | 21 M | ||||
| Net Asset | 103.29 M |
About Trinity Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Trinity Biotech plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trinity Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trinity Biotech plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Trinity Biotech plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Trinity Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Trinity Biotech Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Trinity Biotech Plc Stock:Check out Trinity Biotech Piotroski F Score and Trinity Biotech Altman Z Score analysis. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (1.80) | Revenue Per Share | Quarterly Revenue Growth 0.181 | Return On Assets |
The market value of Trinity Biotech plc is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Biotech's value that differs from its market value or its book value, called intrinsic value, which is Trinity Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Biotech's market value can be influenced by many factors that don't directly affect Trinity Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.